Isaac Kisinovsky

538 total citations
17 papers, 381 citations indexed

About

Isaac Kisinovsky is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Isaac Kisinovsky has authored 17 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Isaac Kisinovsky's work include Lysosomal Storage Disorders Research (17 papers), Trypanosoma species research and implications (6 papers) and Cellular transport and secretion (5 papers). Isaac Kisinovsky is often cited by papers focused on Lysosomal Storage Disorders Research (17 papers), Trypanosoma species research and implications (6 papers) and Cellular transport and secretion (5 papers). Isaac Kisinovsky collaborates with scholars based in Argentina, Paraguay and United States. Isaac Kisinovsky's co-authors include Ricardo Reisin, Cintia Marchesoni, Ari Zimran, Derlis Gonzalez, Elena Lukina, Eric Crombez, Kiran Bhirangi, Hadhami Ben Turkia, Norman W. Barton and Deborah Elstein and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Pediatrics.

In The Last Decade

Isaac Kisinovsky

17 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isaac Kisinovsky Argentina 9 339 126 123 98 94 17 381
Petersen Ee Germany 4 389 1.1× 95 0.8× 207 1.7× 74 0.8× 111 1.2× 10 452
Sudheera Magage Czechia 8 260 0.8× 95 0.8× 149 1.2× 67 0.7× 67 0.7× 16 318
Hui-Ying Yeh Taiwan 4 295 0.9× 83 0.7× 133 1.1× 56 0.6× 93 1.0× 6 326
Ashley N. Gonzalez United States 6 206 0.6× 125 1.0× 83 0.7× 87 0.9× 47 0.5× 13 335
Ken Momosaki Japan 10 163 0.5× 45 0.4× 57 0.5× 102 1.0× 45 0.5× 22 286
Grace A. Ashley United States 7 344 1.0× 100 0.8× 206 1.7× 55 0.6× 135 1.4× 8 375
Irene Viéitez Spain 12 134 0.4× 47 0.4× 57 0.5× 171 1.7× 20 0.2× 21 418
William R. Leahy United States 6 197 0.6× 56 0.4× 82 0.7× 78 0.8× 58 0.6× 9 313
François Eyskens Belgium 8 153 0.5× 49 0.4× 54 0.4× 72 0.7× 44 0.5× 17 292
Kristiane Michelin‐Tirelli Brazil 11 288 0.8× 88 0.7× 123 1.0× 98 1.0× 83 0.9× 23 347

Countries citing papers authored by Isaac Kisinovsky

Since Specialization
Citations

This map shows the geographic impact of Isaac Kisinovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isaac Kisinovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isaac Kisinovsky more than expected).

Fields of papers citing papers by Isaac Kisinovsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isaac Kisinovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isaac Kisinovsky. The network helps show where Isaac Kisinovsky may publish in the future.

Co-authorship network of co-authors of Isaac Kisinovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Isaac Kisinovsky. A scholar is included among the top collaborators of Isaac Kisinovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isaac Kisinovsky. Isaac Kisinovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Reisin, Ricardo, et al.. (2021). Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfa.. PubMed. 81(2). 173–179. 3 indexed citations
2.
Marchesoni, Cintia, Carlos Romero, Isaac Kisinovsky, et al.. (2018). Brain MRI findings in children and adolescents with Fabry disease. Journal of the Neurological Sciences. 395. 131–134. 14 indexed citations
3.
Carmona, Sérgio, et al.. (2017). Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease. Audiology Research. 7(2). 176–176. 8 indexed citations
4.
Reisin, Ricardo, et al.. (2016). Looking for predictors of mortality in patients with Fabry disease on enzyme replacement therapy. Molecular Genetics and Metabolism. 117(2). S99–S100. 2 indexed citations
5.
Mucci, Juan M., et al.. (2015). Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology. Blood Cells Molecules and Diseases. 55(2). 134–143. 24 indexed citations
6.
Rozenfeld, Paula, et al.. (2015). The Continuous Challenge of Diagnosing patients with Fabry disease in Argentina. SHILAP Revista de lepidopterología. 3. 4077973540–4077973540. 4 indexed citations
7.
Cianciulli, Tomás F., et al.. (2015). Apical Left Ventricular Hypertrophy and Mid‐Ventricular Obstruction in Fabry Disease. Echocardiography. 32(5). 860–863. 7 indexed citations
8.
Hughes, Derralynn, Derlis Gonzalez, Elena Lukina, et al.. (2015). Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trials. American Journal of Hematology. 90(7). 584–591. 37 indexed citations
9.
Kisinovsky, Isaac, et al.. (2013). Home infusion program for Fabry disease: experience with agalsidase alfa in Argentina.. PubMed. 73(1). 31–4. 10 indexed citations
10.
Marchesoni, Cintia, Carlos Romero, Gustavo Sevlever, et al.. (2013). Brain MRI findings in Fabry Disease. Journal of the Neurological Sciences. 333. e179–e180. 2 indexed citations
11.
Saccheri, María Cristina, Tomás F. Cianciulli, Jorge A. Lax, et al.. (2013). Two‐Dimensional Speckle Tracking Echocardiography for Early Detection of Myocardial Damage in Young Patients with Fabry Disease. Echocardiography. 30(9). 1069–1077. 51 indexed citations
12.
Gonzalez, Derlis, Hadhami Ben Turkia, Elena Lukina, et al.. (2012). Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study. American Journal of Hematology. 88(3). 166–171. 62 indexed citations
13.
Turkia, Hadhami Ben, Derlis Gonzalez, Norman W. Barton, et al.. (2012). Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease. American Journal of Hematology. 88(3). 179–184. 48 indexed citations
14.
Reisin, Ricardo, et al.. (2011). Brain MRI findings in patients with Fabry disease. Journal of the Neurological Sciences. 305(1-2). 41–44. 48 indexed citations
15.
16.
Marchesoni, Cintia, et al.. (2010). Misdiagnosis in Fabry Disease. The Journal of Pediatrics. 156(5). 828–831. 59 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petersen Ee Breakdown of academic impact, for papers by Sudheera Magage Breakdown of academic impact, for papers by Hui-Ying Yeh Breakdown of academic impact, for papers by Ashley N. Gonzalez Breakdown of academic impact, for papers by Ken Momosaki Breakdown of academic impact, for papers by Grace A. Ashley Breakdown of academic impact, for papers by Irene Viéitez Breakdown of academic impact, for papers by William R. Leahy Breakdown of academic impact, for papers by François Eyskens Breakdown of academic impact, for papers by Kristiane Michelin‐Tirelli
Rankless by CCL
2026